Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
about
Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generationRecombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published dataRecombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use.Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indicationsThe hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplantThe safety and efficacy of the administration of recombinant activated factor VII in major surgery and trauma patients.Pharmacologic interventions for the management of critical bleeding.A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery.Successful use of recombinant activated factor VII for postoperative associated haemorrhage: a case reportRecommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective.Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcome.
P2860
Q28200448-C1749B0D-D7F7-4982-89B9-63DAF55A3C5FQ31146886-3A366AD5-A9A3-4EDD-BA82-B4CFC6CFB9E7Q33633854-4BC4E1A3-8F7F-4327-950C-ACE436F62AB2Q33876266-823825B8-66D7-4B5A-A1FC-D4AA74344CE4Q33911771-357A8896-00FD-47DC-A460-5E4D08528144Q35924900-722F90B9-CA73-40E4-8172-0BB006346A4FQ36150578-050027B6-E627-4885-A866-D89D963C92D7Q36920723-772625E3-C556-49EE-8AEF-F375295146BCQ37095548-4A2BE0EF-8C1D-46C2-B349-06741C2D35BEQ41820542-B2E106A6-719E-41D8-9949-ABDEB736CA25Q43055091-D299EE53-BBF1-4A43-95EE-E7BC5DBEACE3Q50664916-3B44A5E1-7631-4CE9-99C2-761850F1EBD8Q50746970-0746345B-3595-41D8-B0FB-33A14BF77C7E
P2860
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@ast
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@en
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@nl
type
label
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@ast
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@en
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@nl
prefLabel
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@ast
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@en
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@nl
P2093
P2860
P356
P1433
P1476
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
@en
P2093
Anita Aggarwal
Joseph P Catlett
Kirsten Alcorn
Vera Malkovska
P2860
P2888
P356
10.1186/1477-9560-2-9
P577
2004-01-01T00:00:00Z
P5875
P6179
1028675512